Hubei Biocause Pharmaceutical Co., Ltd. provided earnings guidance for the first quarter of 2014. The company expects net profit of CNY 193 million to CNY 196 million in the first quarter of 2014, turning losses of CNY 5.9521 million a year earlier.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 CNY | 0.00% |
|
-4.57% | -33.80% |
10:15am | Biocause Pharma Plans Buyback of Up to 100 Million Yuan Shares | MT |
04-29 | Hubei Biocause Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.80% | 1.28B | |
+1.66% | 69.29B | |
+6.08% | 49.46B | |
+3.99% | 48.75B | |
+18.07% | 44.91B | |
+9.73% | 40.62B | |
+19.34% | 37.4B | |
+19.72% | 34.09B | |
-5.27% | 27.56B | |
-11.04% | 26.6B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Hubei Biocause Pharmaceutical Provides Earnings Guidance for the First Quarter of 2014